Evidence map›Paper›PMID 23243472›Full record

ArticleBeilstein journal of organic chemistry2012

Multivalent display of the antimicrobial peptides BP100 and BP143.

Imma Güell, Rafael Ferre, Kasper Kildegaard Sørensen, Esther Badosa, Iteng Ng-Choi, Emilio Montesinos, Eduard Bardají, Lidia Feliu, Knud J Jensen, Marta Planas

Abstract read
In one paragraph

Article in Beilstein journal of organic chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Deciphering the Mechanism of Action of the Antimicrobial Peptide BP100.International journal of molecular sciences · 2024
    Review
  2. Article
  3. Review
  4. Assembly of synthetic Aβ miniamyloids on polyol templates.Beilstein journal of organic chemistry · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Imma GüellLIPPSO, Department of Chemistry, University of Girona, Campus Montilivi, 17071 Girona, Spain.
Rafael Ferre
Kasper Kildegaard Sørensen
Esther Badosa
Iteng Ng-Choi
Emilio Montesinos
Eduard Bardají
Lidia Feliu
Knud J Jensen
Marta Planas

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbohydrates are considered as promising templates for the display of multiple copies of antimicrobial peptides. Herein, we describe the design and synthesis of chimeric structures containing two or four copies of the antimicrobial peptides KKLFKKILKYL-NH(2) (BP100) and KKLfKKILKYL-NH(2) (BP143) attached to the carbohydrate template cyclodithioerythritol (cDTE) or α-D-galactopyranoside (Galp). The synthesis involved the preparation of the corresponding peptide aldehyde followed by coupling to an aminooxy-functionalized carbohydrate template. After purification, the multivalent display systems were obtained in high purities (90-98%) and in good yields (42-64%). These compounds were tested against plant and human pathogenic bacteria and screened for their cytotoxicity on eukaryotic cells. They showed lower MIC values than the parent peptides against the bacteria analyzed. In particular, the carbopeptides derived from cDTE and Galp, which contained two or four copies of BP100, respectively, were 2- to 8-fold more active than the monomeric peptide against the phytopathogenic bacteria. These results suggest that preassembling antimicrobial peptides to multimeric structures is not always associated with a significant improvement of the activity. In contrast, the carbopeptides synthesized were active against human red blood cells pointing out that peptide preassembly is critical for the hemolytic activity. Notably, peptide preassembly resulted in an enhanced bactericidal effect.

Indexed as

antimicrobial activitycarbopeptidesmultimeric structuresoxime ligationphytopathogenic bacteria

Identifiers

PMID23243472
PMCPMC3520567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.